RedHill Biopharma reported $702K in Cost of Sales for its fiscal quarter ending in June of 2024.


Cost Of Sales Change Date
Clal Biotechnology ILS 16.49M 2.64M Jun/2022
Compugen USD 1.66M 985K Jun/2025
Cronos Group USD 19.65M 1.12M Jun/2025
RedHill Biopharma USD 702K 0 Jun/2024